Rchr
J-GLOBAL ID：201601005126894363   Update date: May. 31, 2024

Kashiwakura Junichi

カシワクラ ジュンイチ | Kashiwakura Junichi
Affiliation and department：
Hokkaido University of Science Faculty of Pharmaceutical Sciences, Department of Life Sicence

About Hokkaido University of Science Faculty of Pharmaceutical Sciences, Department of Life Sicence


Job title： Professor
Research field  (5)： Cell biology ,  Molecular biology ,  Allergies and connective tissue disease ,  Immunology ,  Pharmaceuticals - health and biochemistry
Research theme for competitive and other funds  (5)：
  • 2024 - 2027 マスト細胞活性化反応におけるSTAP-1抑制機構の解明
  • 2021 - 2024 Analysis of function of STAP-1 for mast cell activation and pathogenesis of bronchial asthma
  • 2019 - 2022 Study of signaling pathways for treatment of immune/allergic diseases
  • 2015 - 2018 The role of HRF in pollinosis
  • 2013 - 2015 Investigation of HRF-mediated amplifying mechanism in food allergy
Papers (111)：
  • Kota Kagohashi, Yuto Sasaki, Kiyotaka Ozawa, Takuya Tsuchiya, Shoya Kawahara, Kodai Saitoh, Michiko Ichii, Jun Toda, Yasuyo Harada, Masato Kubo, et al. Role of Signal-Transducing Adaptor Protein-1 for T Cell Activation and Pathogenesis of Autoimmune Demyelination and Airway Inflammation. The Journal of Immunology. 2024
  • Jun-Ichi Kashiwakura, Keigo Nishida. [Progressing Basic Immunology for Development of New Therapeutic Medicines]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2024. 144. 5. 473-474
  • Jun-Ichi Kashiwakura, Tadashi Matsuda. [Understanding New Regulatory Mechanism of TCR Signal Transduction]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2024. 144. 5. 497-501
  • Yuto Sasaki, Shoya Kawahara, Yuichi Sekine, Jun-Ichi Kashiwakura, Kenji Oritani, Tadashi Matsuda. Potential therapeutic applications of targeting signal-transducing adaptor protein-2 in autoimmune diseases. Exploration of Immunology. 2023. 3. 6. 604-612
  • Jun-Ichi Kashiwakura, Shoya Kawahara, Iori Inagaki, Kyosuke Inui, Kodai Saitoh, Kota Kagohashi, Yuto Sasaki, Fuki Kobayashi, Yuichi Kitai, Ryuta Muromoto, et al. STAP-2 negatively regulates BCR-mediated B cell activation by recruiting tyrosine-protein kinase CSK to LYN. FEBS letters. 2023. 597. 19. 2433-2445
ｍore...
MISC (47)：
ｍore...
Patents (1)：
Books (2)：
  • Monomeric IgE and Mast cell Development, Survival and Function. Mast Cell Biology: Contemporary and Emerging Topics (Edited by Gilfillan A.M. and Metcalfe D.D.).
    Adv. Exp. Med. Biol. 2011
  • Selective downregulation of FcgammaRI and FcepsilonRI in cord blood-derived vs adult peripheral blood-derived cultured human mast cells (Edited by Bienenstock J., Ring J. and Togias A.G.).
    Allergy Frontiers and Futures. 2004
Lectures and oral presentations  (102)：
  • STAP-2 negatively regulates B cell receptor-mediated B cell activation and allergic rhinitis.
    (第50回日本免疫学会総会・学術集会 2022)
  • New strategy of STAP-2-based suppression of TCR-mediated T cell activation and autoimmune encephalomyelitis.
    (第50回日本免疫学会総会・学術集会 2021)
  • STAP-1 is involved in TCR-mediated T cell activation and pathogenesis of multiple sclerosis.
    (第50回日本免疫学会総会・学術集会 2021)
  • 突発性肺線維症病態形成に対するアダプター分子STAP-2の機能解析
    (日本薬学会北海道支部第148回例会 2021)
  • STAP-2によるB細胞活性化制御機構の解明
    (日本薬学会北海道支部第148回例会 2021)
ｍore...
Education (2)：
  • 1997 - 2002 Hoshi University
  • 1993 - 1997 Hoshi University Hoshi University Hoshi University
Professional career (1)：
  • 博士(薬学) (星薬科大学)
Work history (9)：
  • 2022/04 - 現在 北海道大学 大学院薬学研究院
  • 2022/04 - 現在 Hokkaido University of Science Faculty of Pharmaceutical Sciences, Department of Life Science Professor
  • 2016/10 - 2022/03 Hokkaido University Faculty of Pharmaceutical Sciences Lecturer
  • 2016/04 - 2016/09 Nihon University School of Medicine Research Scientist
  • 2013/04 - 2016/03 RIKEN Center for Integrative Medical Sciences Senior Research Scientist
Show all
Committee career (4)：
  • 2023 - 現在 日本薬学会 代議員
  • 2021/01 - 現在 日本免疫学会 評議員
  • 2013/12 - 2016/03 RIKEN IMS-JSI 国際シンポジウム実行委員
  • 2010/10 - 2012/03 第61回日本アレルギー学会学術大会大会実行委員
Association Membership(s) (2)：
THE PHARMACEUTICAL SOCIETY OF JAPAN ,  THE JAPANESE SOCIETY FOR IMMUNOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM